Immunology and Microbiology
Giant Cell Arteritis
100%
Rheumatic Polymyalgia
61%
Macrophage
30%
Kidney Transplantation
26%
Positron Emission Tomography-Computed Tomography
25%
Adenoviridae
22%
Vasculitis
20%
Glucocorticoid
18%
Reperfusion
16%
Artery
16%
Temporal Artery
16%
B Cell
15%
Cytotoxic T-Cell
15%
Transplant Procedure
14%
Fibroblast
13%
Positron Emission Tomography
13%
Immunosuppressive Therapy
11%
Angiopoietin 2
10%
Granulocyte Macrophage Colony-Stimulating Factor
9%
Interleukin-6
9%
Blood Level
9%
Macrophage Subset
9%
Interleukin 13
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Indoleamine 2,3-dioxygenase
9%
Vaccine Efficacy
9%
Bursitis
9%
Interleukin 6
9%
Vaccination Policy
8%
Allotransplantation
8%
Angiogenesis
8%
T Cell
7%
Cytokine
7%
Synovial Fluid
7%
Inflammatory Disorder
6%
Kidney Function
6%
Acute Graft Rejection
6%
T-Helper Cell
5%
Immunosuppressive Drug
5%
Dynamics
5%
Tenosynovitis
5%
Leukocyte
5%
Medicine and Dentistry
Giant-Cell Arteritis
51%
Positron Emission Tomography-Computed Tomography
31%
Gene Therapy
27%
Polymyalgia Rheumatica
24%
Positron Emission Tomography
23%
Vasculitis
22%
Fluorodeoxyglucose F 18
19%
Diagnostic Accuracy
19%
Kidney Transplantation
16%
Adenoviridae
15%
Macrophage
14%
Temporal Artery
14%
Diagnosis
13%
Reperfusion Injury
10%
Systematic Review
9%
Meta-Analysis
9%
Interleukin 13
9%
Kidney Ischemia
9%
Deoxyglucose
9%
Disease
9%
Immunosuppressive Treatment
8%
Artery
7%
Blood Vessel Biopsy
6%
Glucocorticoid
6%
Epidermal Growth Factor Receptor
6%
Nephropathy
5%
Symptom
5%
Kidney Function
5%
Patient Monitoring
5%
Synovial Fluid
5%
Injury
5%
Angiogenesis
5%
Kidney Injury
5%
Keyphrases
Giant Cell Arteritis
37%
Polymyalgia Rheumatica
28%
Diagnostic Accuracy
9%
Positron Emission Tomography-computed Tomography (PET-CT)
9%
Gene Therapy
9%
Large-vessel Giant Cell Arteritis
9%
Vasculitis
8%
Adenovirus
8%
Interleukin-6
6%
Fibroblasts
6%
Kidney
6%
Macrophages
6%
18F-FDG PET-CT
6%
CD4+ T Cells
5%
Current Management
5%
Classification Criteria
5%
European League against Rheumatism (EULAR)
5%
